These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14938444)

  • 1. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
    SIROTA JH; YU TF; GUTMAN AB
    J Clin Invest; 1952 Jul; 31(7):692-701. PubMed ID: 14938444
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.
    BISHOP C; RAND R; TALBOTT JH
    J Clin Invest; 1951 Aug; 30(8):889-95. PubMed ID: 14861311
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of p-(di-n-propylsulfamyl)-benzoic acid on the excretion of uric acid.
    PITTS FW; CHAMBERS JS
    U S Armed Forces Med J; 1952 Aug; 3(8):1219-24. PubMed ID: 14942976
    [No Abstract]   [Full Text] [Related]  

  • 4. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.
    GUTMAN AB; YU TF
    Trans Assoc Am Physicians; 1951; 64():279-88. PubMed ID: 14884260
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.
    BEYER KH; RUSSO HF; TILLSON EK; MILLER AK; VERWEY WF; GASS SR
    Am J Physiol; 1951 Sep; 166(3):625-40. PubMed ID: 14885452
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of the prolonged administration of p-(di-n-propylsulfamyl)-benzoic acid (benemid) upon plasma concentrations of para-aminosalicylic acid.
    ISRAEL HL; MICK F; BOGER WP
    Am Rev Tuberc; 1951 Oct; 64(4):454-60. PubMed ID: 14885676
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of p.(di-n-propylsulfamyl) benzoic acid (benemid) on free and total sulfonamide plasma levels.
    CROSLEY AP; BAYNE GM; CARFAGNO SC; BOGER WP
    J Lab Clin Med; 1952 Nov; 40(5):730-5. PubMed ID: 12990901
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels.
    García Puig J; Mateos Antón F; López Jiménez M; Conthe Gutiérrez P
    Metabolism; 1986 Dec; 35(12):1147-53. PubMed ID: 3784914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of P-(di-n-propylsulfamyl)-benzoic acid (benemid) to influence p-aminosalicylic acid blood levels.
    RILEY C; CLOWATER RA; SHANE SJ
    Dis Chest; 1953 Jan; 23(1):90-3. PubMed ID: 12998452
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
    RIEBER CW; SALINE M; FRIEDMAN MM
    Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of probenecid (p-[di-n-propylsulphamyl]-benzoic acid) on uric acid excretion and plasma uric acid level in normal human subjects.
    CRONE C; LASSEN UV
    Acta Pharmacol Toxicol (Copenh); 1955; 11(3):295-300. PubMed ID: 13301777
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the uricosuric action of benemid by salicylate.
    PASCALE LR; DUBIN A; BRONSKY D; HOFFMAN WS
    J Lab Clin Med; 1955 May; 45(5):771-7. PubMed ID: 14368045
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of benemid [p-(di-n-propylsulfamyl)benzoic acid] on blood levels of PAS.
    JANSZEN H
    J Lab Clin Med; 1951 Aug; 38(2):227-33. PubMed ID: 14861520
    [No Abstract]   [Full Text] [Related]  

  • 14. Benemid, p-(DI-n-propylsulfamyl)-benzoic acid; toxicologic properties.
    McKINNEY SE; PECK HM; BOCHEY JM; BYHAM BB; SCHUCHARDT GS; BEYER KH
    J Pharmacol Exp Ther; 1951 Jul; 102(3):208-14. PubMed ID: 14851208
    [No Abstract]   [Full Text] [Related]  

  • 15. Calciuric effect of probenecid in gouty patients.
    Weinberger A; Schindel B; Liberman UA; Pinkhas J; Sperling O
    Isr J Med Sci; 1983 Apr; 19(4):377-9. PubMed ID: 6853140
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of p-(di-n-propylsulfamyl)-benzoic acid, "benemid", on para-aminosalicylic acid (PAS) plasma concentrations.
    BOGER WP; PITTS FW
    Am Rev Tuberc; 1950 Jun; 61(6):862-7. PubMed ID: 15413771
    [No Abstract]   [Full Text] [Related]  

  • 17. The renal excretion of thiamine during administration of probenecid (p-(di-N-propylsulfamyl)-benzoic acid).
    HAUGEN HN
    Scand J Clin Lab Invest; 1961; 13():661-4. PubMed ID: 13905394
    [No Abstract]   [Full Text] [Related]  

  • 18. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O; Wyngaarden JB; Starmer CF
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glycine loading on plasma and urinary uric acid and amino acids in normal and gouty subjects.
    Yü TF; Kaung C; Gutman AB
    Am J Med; 1970 Sep; 49(3):352-9. PubMed ID: 5455567
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.
    YU TF; SIROTA JH; GUTMAN AB
    J Clin Invest; 1953 Nov; 32(11):1121-32. PubMed ID: 13108975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.